CSIMarket
 


Integrated Biopharma Inc  (INBP)
Other Ticker:  
 


Integrated Biopharma Inc's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



INBP Net Cash Flow Margin (Sep 30 2022)
I. Quarter
(Jun 30 2022)
IV. Quarter
(Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
(Sep 30 2021)
I. Quarter
Y / Y Revenue Change -3.33 % -22.22 % -8.42 % 2.36 % -15.96 %
Seq. Revenue Change -7.09 % -15.14 % 7.13 % 14.45 % -25.25 %
Revenue In Millions $12.33 $13.27 $15.63 $14.59 $12.75
Net Cash Flow Margin 6.79 % 0.51 % 0.65 % 0.72 % -1.2 %
Net Cash Flow Margin Total Ranking # 1188 # 1583 # 1591 # 2166 #
Net Cash Flow In Millions $0.84 $0.07 $0.10 $0.11 $-0.15
Y / Y Net Cash Flow Change - -36.19 % 64.52 % - -
Seq. Net Cash Flow Change 1149.25 % -34.31 % -2.86 % - -


Commenting First Quarter 2022 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in I. Quarter to 6.79 %, a new company high.

Observing first quarter 2022 results within Major Pharmaceutical Preparations industry 115 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin total ranking has impoved so far to 1188, from total ranking in previous quarter at 1583.

INBP's Net Cash Flow Margin first quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 116
Healthcare Sector # 244
Overall # 1187

Net Cash Flow Margin Statistics
High Average Low
6.79 % 1.57 % 0.08 %
(Sep 30 2022)   (Mar 31 2018)




Other Net Cash Flow Margin Profitability Ratios
INBP's Cumulative Net Cash Flow Margin
Major Pharmaceutical Preparations Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
INBP's Net Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for INBP's Competitors
Net Cash Flow Margin Profit Margin for Integrated Biopharma Inc's Suppliers
Net Cash Flow Margin Profit Margin for INBP's Customers

You may also want to know
INBP's Annual Growth Rates INBP's Profitability Ratios INBP's Asset Turnover Ratio INBP's Dividend Growth
INBP's Roe INBP's Valuation Ratios INBP's Financial Strength Ratios INBP's Net Cash Flow Growth
INBP's Roa INBP's Inventory Turnover Ratio INBP's Growth Rates INBP's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Net Cash Flow MarginSep 30 2022 MRQ Net Cash FlowSep 30 2022 MRQ Revenue
Aytu Biopharma inc   16.09 %$ 4.451 $ 27.655 
Myovant Sciences Ltd   15.82 %$ 16.581 $ 104.824 
Corcept Therapeutics Inc  14.64 %$ 14.897 $ 101.728 
Jazz Pharmaceuticals Plc  13.62 %$ 128.093 $ 940.652 
Athenex Inc   11.99 %$ 4.019 $ 33.530 
Rigel Pharmaceuticals Inc  11.89 %$ 2.665 $ 22.410 
Xencor Inc  11.88 %$ 3.244 $ 27.299 
Cumberland Pharmaceuticals Inc   11.61 %$ 1.325 $ 11.413 
Acadia Pharmaceuticals Inc   11.48 %$ 15.009 $ 130.714 
Merck and Co Inc   10.20 %$ 1,526.000 $ 14,959.000 
Collegium Pharmaceutical inc   8.98 %$ 11.404 $ 127.013 
Aquestive Therapeutics Inc   8.32 %$ 0.954 $ 11.463 
Clene Inc   8.05 %$ 0.014 $ 0.174 
Heron Therapeutics Inc   6.89 %$ 1.829 $ 26.557 
Integrated Biopharma Inc  6.79 %$ 0.837 $ 12.326 
Abbott Laboratories  6.31 %$ 657.000 $ 10,410.000 
Lftd Partners Inc   5.34 %$ 0.600 $ 11.237 
Landec Corporation  5.15 %$ 2.231 $ 43.355 
International Stem Cell Corporation  4.70 %$ 0.080 $ 1.703 
Teva Pharmaceutical Industries Limited  4.65 %$ 167.000 $ 3,595.000 
American Bio Medica Corporation  3.83 %$ 0.008 $ 0.209 
Therapeuticsmd Inc   3.71 %$ 0.777 $ 20.917 
Alkermes Plc   3.69 %$ 9.311 $ 252.357 
Regeneron Pharmaceuticals Inc   3.28 %$ 96.200 $ 2,936.200 
Prestige Consumer Healthcare Inc   2.27 %$ 6.573 $ 289.273 
Akebia Therapeutics Inc   1.77 %$ 0.868 $ 48.964 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EGY's Profile

Stock Price

EGY's Financials

Business Description

Fundamentals

Charts & Quotes

EGY's News

Suppliers

EGY's Competitors

Customers & Markets

Economic Indicators

EGY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071